Concepedia

Publication | Closed Access

LBA30 ATHENA-COMBO, a phase III, randomized trial comparing rucaparib (RUCA) + nivolumab (NIVO) combination therapy vs RUCA monotherapy as maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC)

DOI

29

Citations

0

References

2024

Year

B.J. Monk, A. Oaknin, David M. O’Malley, M. Wilson, Domenica Lorusso, Shannon N. Westin, Amit M. Oza, Flora Zagouri, T.J. Herzog, Olga Mikheeva,
Annals of Oncology

No additional data available for this publication yet. Check back later!